Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure
NCT02429388Phase 4Withdrawn
- Sponsor
- UT Health San Antonio
- Start
- May 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in heart failure (HF), sponsored by UT Health San Antonio. Planned start May 2014; status: withdrawn.
02
Drugs
spironolactone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02429388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429388.